Tirzepatide is a synthetic, modified incretin peptide analogue used in qualified laboratory research involving GIP and GLP-1 receptor signalling models. It is an acylated peptide with sequence modifications and is typically studied for multi-receptor peptide design and metabolic signalling pathway research.
Tirzepatide is a synthetic, modified incretin peptide analogue used in qualified laboratory research involving GIP and GLP-1 receptor signalling models. It is an acylated peptide with sequence modifications and is typically studied for multi-receptor peptide design and metabolic signalling pathway research. This material should be supplied strictly as a research compound and not as a medical product.
